PMID- 32939611 OWN - NLM STAT- MEDLINE DCOM- 20210713 LR - 20210713 IS - 1568-5608 (Electronic) IS - 0925-4692 (Linking) VI - 28 IP - 6 DP - 2020 Dec TI - Antinociception induced by artemisinin nanocapsule in a model of postoperative pain via spinal TLR4 inhibition. PG - 1537-1551 LID - 10.1007/s10787-020-00756-w [doi] AB - Artemisinin (ART) was initially described for the control of inflammation and pain. However, the mechanisms involved with its antinociceptive effect are still poorly understood. Thus, this present study aimed to investigate the effect of ART in both free and nanocapsulated form on postoperative pain, as well as the participation of the spinal Toll-like receptor 4 (TLR4) in this process. Postoperative pain was induced using the skin/muscle incision retraction (SMIR) model in male Swiss mice. After 3 and 28 days of SMIR, the animals received an intrathecal injection of free or nanocapsulated ART, and the nociceptive threshold was evaluated by von Frey filament test. To evaluate the involvement of the microglia, astrocytes, and TLR4, minocycline (a microglia inhibitor), fluorocitrate (an astrocyte inhibitor), and Lipopolysaccharide Rhodobacter sphaeroides (LPS-RS), a TLR4 antagonist, were intrathecally injected on the third day of SMIR. The levels of spinal TLR4 protein and proinflammatory cytokines tumor necrosis factor-alpha (TNF-alpha), and interleukin-1-beta (IL-1beta) were quantified by western blot and enzyme-linked immunosorbent assay, respectively. The results showed that free ART reduced postoperative pain (P < 0.001, F(5,30) = 7.49, 16.66% for 1000 ng dose; and P < 0.01, F(5,30) = 7.49, 14.58% for 500 ng dose) on the 3rd day of SMIR; while the ART nanocapsule had this effect on both the third (P < 0.001; F(5,30) = 4.94; 43.75, 39.58 and 72.91% for the 250, 500 and 1000 ng doses, respectively) and 28th (P < 0.05; F(5,30) = 7.71; 29.16 and 33.33% for the 500 and 1000 ng doses, respectively) day. The ART nanocapsule had a more potent and longer antinociceptive effect than free ART or morphine. Postoperative pain was also reduced by minocycline and LPS-RS. The ART nanocapsule also reduced the increased levels of TLR4, TNF-alpha, and IL-1beta induced by SMIR. These data suggest that the ART nanocapsule has a potent analgesic effect on postoperative pain at the spinal level, and this response involves the inhibition of TLR4 and the proinflammatory cytokines TNF-alpha and IL-1beta. FAU - Elisei, L M S AU - Elisei LMS AD - Sciences of Motricity Institute, Faculty of Motricity Sciences, Federal University of Alfenas, Jovino Fernandes Sales Ave. 2600, Alfenas, 37133-840, Brazil. FAU - Moraes, T R AU - Moraes TR AD - Sciences of Motricity Institute, Faculty of Motricity Sciences, Federal University of Alfenas, Jovino Fernandes Sales Ave. 2600, Alfenas, 37133-840, Brazil. FAU - Malta, I H AU - Malta IH AD - Sciences of Motricity Institute, Faculty of Motricity Sciences, Federal University of Alfenas, Jovino Fernandes Sales Ave. 2600, Alfenas, 37133-840, Brazil. FAU - Charlie-Silva, I AU - Charlie-Silva I AD - Department of Pharmacology, University de Sao Paulo, Sao Paulo, Brazil. FAU - Sousa, I M O AU - Sousa IMO AD - Faculty of Pharmaceutical Sciences, University of Campinas, Campinas, Brazil. FAU - Veras, F P AU - Veras FP AD - Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil. FAU - Foglio, M A AU - Foglio MA AD - Faculty of Pharmaceutical Sciences, University of Campinas, Campinas, Brazil. FAU - Fraceto, L F AU - Fraceto LF AD - Institute of Science and Technology, Sao Paulo State University, Sorocaba, Brazil. FAU - Galdino, G AU - Galdino G AUID- ORCID: 0000-0002-1898-1973 AD - Sciences of Motricity Institute, Faculty of Motricity Sciences, Federal University of Alfenas, Jovino Fernandes Sales Ave. 2600, Alfenas, 37133-840, Brazil. giovanegsouza@yahoo.com.br. LA - eng GR - 001/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/ GR - 2014/16008-3/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/ PT - Journal Article DEP - 20200916 PL - Switzerland TA - Inflammopharmacology JT - Inflammopharmacology JID - 9112626 RN - 0 (Analgesics) RN - 0 (Artemisinins) RN - 0 (Cytokines) RN - 0 (Nanocapsules) RN - 0 (Tlr4 protein, mouse) RN - 0 (Toll-Like Receptor 4) SB - IM MH - Analgesics/*pharmacology MH - Animals MH - Artemisinins/*pharmacology MH - Cytokines/metabolism MH - Hyperalgesia/drug therapy/metabolism MH - Male MH - Mice MH - Microglia/drug effects/metabolism MH - Nanocapsules/*administration & dosage MH - Pain, Postoperative/*drug therapy/metabolism MH - Spinal Cord/*drug effects/metabolism MH - Toll-Like Receptor 4/*antagonists & inhibitors MH - Up-Regulation/drug effects OTO - NOTNLM OT - Artemisinin OT - Postoperative pain OT - Proinflammatory cytokines OT - Spinal cord OT - Toll-like receptor 4 EDAT- 2020/09/18 06:00 MHDA- 2021/07/14 06:00 CRDT- 2020/09/17 05:46 PHST- 2020/05/07 00:00 [received] PHST- 2020/09/05 00:00 [accepted] PHST- 2020/09/18 06:00 [pubmed] PHST- 2021/07/14 06:00 [medline] PHST- 2020/09/17 05:46 [entrez] AID - 10.1007/s10787-020-00756-w [pii] AID - 10.1007/s10787-020-00756-w [doi] PST - ppublish SO - Inflammopharmacology. 2020 Dec;28(6):1537-1551. doi: 10.1007/s10787-020-00756-w. Epub 2020 Sep 16.